Sample Sizes Based on Exact Unconditional Tests for Phase II Clinical Trials with Historical Controls

Journal of Biopharmaceutical Statistics

Volumn 14, Issue 1, 2004, Pages 189-200

  Chang, Myron N ^a   Shuster, Jonathan J ^a   Kepner, James L ^b  

^a University of Florida ^*  (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Binomial distribution; Exact unconditional Z test; Historical controls; Phase II trials; Single stage design

Indexed keywords

BINOMIAL DISTRIBUTION; CLINICAL STUDY; CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; STATISTICS; VARIANCE;

CLINICAL TRIALS, PHASE II; HUMANS; MODELS, STATISTICAL; SAMPLE SIZE;

EID: 1542288978     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-120028514     Document Type: Review

References (18)

1. Berger, R., Boos, D. S. (1994). P values maximized over a confidence set for the nuisance parameter. J. Amer. Stat. Assoc. 89(427):1012-1016.
2. Bickel, P. J., Doksum, K. A. (1977). Mathematical Statistics: Basic Ideas and Selected Topics. San Franciso: Holden-Day.
3. Casella, G., Berger, R. L. (1990). Statistical Inference. Pacific Grove, California: Wadsworth & Books/Cole.
4. Chang, M. N., Shuster, J. J., Kepner, J. L. (1999). Group sequential designs for phase II trials with historical controls. Controlled Clin. Trials 20:353-364.
5. Devidas, M., Kepner, J. L. (2000). On Computing Sample Size for Phase II Efficacy Studies with Historical Controls, University of Florida, Department of Statistics Technical Report 2000-033.
6. Elfenbein, G., Krischer, J., Rand, K., Graham-Pole, J., Jansen, J., Winston, G., Hong, R., Lazarus, H., Babington, R. (1987). Preliminary results of a multicenter trial to prevent death from cytomegalovirus pneumonia with intravenous immunoglobulin after allogeneic bone marrow transplantation. Transplant Proc. 19(6, Suppl. 7):138-143.
7. Fleming, T. R. (1987). Treatment evaluation in active control studies. Cancer Treatment Reports 71(11):1061-1065.
8. Ihde, D. C., Deisseroth, A. B., Lichter, A. S., Bunn, P. A., Carney, D. N., Cohen, M. H., Veach, S. R., Makuch, R. W., Johnston-Early, A., Abrams, R. A., Messenschmidt, G. L., Mathews, M. J., Minna, J. D. (1986). Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J. Clin. Oncol. 4(10):1443-1454.
9. Kepner, J. L., Wackerly, D. D. (2001). Some observations on the makuch/simon approach to sample size determination in clinical trials with historical controls. Commun. Stat. Simulation Comput. 30(3):611-621.
10. Krischer, J., Elfenskein, G., Babington, R., Hong, R., Janson, J., Lazarus, H., Winston, E., Rand, K. (1992). Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin. Seminars in Hematology 29(3, Suppl. 2):89-95.
11. Makuch, R. W., Simon, R. M. (1980). Sample size considerations for nonrandomized comparative studies. J. Chronical Dis. 33:175-181.
12. Pile, G., Kreuzer, E., Kaab, S., Appel, R., Werdan, K. (1994). Early sepis treatment with immunoglobulins after cardiac surgery in score - identified high-risk patients. Chest 105:76-82.
13. Pliz, G., Kaab, S., Neeser, G., Class, I., Schweigart, U., Brahler, A., Bujdoso, O., Neumann, R. (1991). Supplemental immunoglobin (iv) IgG treatment in 163 patients with sepsis and septic shock-an observational study as a prerequisite for placebo-controlled clinical trials. Infection 19(4):216-227.
14. Shuster, J. J. (1988). EXACT B and CONF: Exact unconditonal procedures for binomial data. Amer. Statist. 42(3):234.
15. Simon, R. M., Dixon, D. O. (1989). Sample size considerations for studies comparing survival curves using historical controls. J. Clin. Epidemiol. 41:1209-1213.
16. StatXact Version 5 (2002) Cytel Software Corp. Cambridge, MA.
17. Suissa, S., Shuster, J. J. (1985). Exact unconditional sample sizes for the 2 x 2 Binomial trial. J. Roy. Stat. Soc. A 148(Part 4):317-327.
18. Wolff, S. N., Phillips, G. L., Herzig, G. P. (1987). High dose carmustine with autologous bone marrow transplantation for the ajuvant treatment of high-grade gliomas of the central nervous system. Cancer Treatment Rep. 71(2):183-185.